Uta Kemmerich-Keil

Uta Kemmerich-Keil currently serves as Co-Managing Director at Chemitra GmbH, Director at Klosterfrau Zürich AG, Director at FARCO-PHARMA GmbH, Director at Maria Clementine Martin Klosterfrau Vertriebsgesellschaft mbH, Independent Member of the Supervisory Board at Beiersdorf AG since 2022, Member of the Supervisory Board at SCHOTT AG, Member of the Supervisory Board at Röchling SE & Co. KG, Independent Non-Executive Director at British American Tobacco plc starting in 2025, and Member of the Supervisory Board at Lanxess AG starting in 2026.
Former roles include President & CEO of Merck Consumer Health Division at Merck KGaA from 2014 to 2018, President & Chief Executive Officer at Merck Consumer Health Holding GmbH, CEO of Personal Healthcare International at Procter & Gamble AG from 2018 to 2020, Chief Executive Officer at Allergopharma GmbH & Co. KG from 2012 to 2014, Director at GOTHAER Versicherungsbank VVaG, Co-Managing Director at Merck Selbstmedikation GmbH, Independent Director at Karo Healthcare AB, Senior Financial Auditor at Hoechst AG from 1996 to 1999, Assistant Professor in the Roman Philology Department at the University of Freiburg from 1993 to 1995, Member of the Supervisory Board at Biotest GmbH & Co. KGaA, and Member of the Supervisory Board at Affimed NV from 2021 to 2024.
Education includes undergraduate and graduate degrees from the University of Freiburg.